Bruno Hoen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bruno Hoen has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Christine Selton-Suty
Cardiology, CHRU de Nancy, Nancy, France
3 shared publications Xavier Duval
3 shared publicationsAlain Venet
2 shared publications- Bernard Iung
Hôpital Bichat, Paris, France
2 shared publications C. Chirouze
University Hospital of Besançon
2 shared publicationsC. H. Cabell
Duke University Medical Center
2 shared publications
Latest Publications
- 22 August 2013
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 369 (8) , 784-785
Infective Endocarditis
In their review on infective endocarditis, Hoen and Duval (April 11 issue)1 advocate that when valve replacement is performed during antibiotic treatment for native-valve infective endocarditis, antimicrobial therapy should not be switched to that recommended for prosthetic-valve infective endocarditis. Although supported by few data, such a strategy is in line with the 2009 European Society of Cardiology guidelines.2 However, to our knowledge, only one retrospective study conducted at a single center with a small sample is available on the topic, and it showed cure rates that were similar regardless of the antimicrobial regimen administered.3 By contrast, the 2005 American Heart Association guidelines recommend that for patients with native-valve infective endocarditis who undergo valve replacement with a prosthetic valve, the postoperative treatment regimen should be the one recommended for the treatment of prosthetic-valve infective endocarditis rather than the one recommended for the treatment of native-valve infective endocarditis.4 Thus, regarding valve replacement performed during antibiotic treatment of native-valve infective endocarditis, there is still debate about whether to switch antimicrobial therapy to the treatment recommended for prosthetic-valve infective endocarditis. Further studies are needed to address this critical issue.
- 22 August 2013
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 369 (8) , 784-785
Infective Endocarditis
In their review on infective endocarditis, Hoen and Duval (April 11 issue)1 advocate that when valve replacement is performed during antibiotic treatment for native-valve infective endocarditis, antimicrobial therapy should not be switched to that recommended for prosthetic-valve infective endocarditis. Although supported by few data, such a strategy is in line with the 2009 European Society of Cardiology guidelines.2 However, to our knowledge, only one retrospective study conducted at a single center with a small sample is available on the topic, and it showed cure rates that were similar regardless of the antimicrobial regimen administered.3 By contrast, the 2005 American Heart Association guidelines recommend that for patients with native-valve infective endocarditis who undergo valve replacement with a prosthetic valve, the postoperative treatment regimen should be the one recommended for the treatment of prosthetic-valve infective endocarditis rather than the one recommended for the treatment of native-valve infective endocarditis.4 Thus, regarding valve replacement performed during antibiotic treatment of native-valve infective endocarditis, there is still debate about whether to switch antimicrobial therapy to the treatment recommended for prosthetic-valve infective endocarditis. Further studies are needed to address this critical issue.
- Open Access
- 8 May 2013
- Published by Wiley in HIV Medicine
- Vol. 14 (8) , 509-515
An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy
Objectives: The aim of the study was to assess whether patients with undetectable viraemia [a negative polymerase chain reaction result (PCRneg)] and those with plasma viral load (PVL) < 40 HIV‐1 RNA copies/mL but a detectable (positive) PCR signal (PCRpos) had different outcomes in terms of the development of blips and virological failure (VF).Methods: A multicentre observational database analysis was carried out. Data for patients whose highly active antiretroviral therapy (HAART) regime had been unchanged for ≥ 6 months by 1 January 2008, whose first two PVL measurements of 2008 were < 40 copies/mL and who had at least five PVL measurements between 1 January 2008 and 31 December 2010 were extracted from a multicentre observational database of 4928 patients receiving HAART. PVL assays used during this period had a detection threshold of 20 or 40 copies/mL. Undetectable PVL at baseline (BLPCRneg) was defined as PCRneg at the first two PVL determinations of 2008. Multivariable Cox regression analysis was performed to investigate factors associated with the occurrence of blips and VF, defined as two consecutive PVL measurements > 40 copies/mL.Results: Of the 1957 patients included in the study (mean age 47 years; median antiretroviral exposure 10.3 years), 1312 had BLPCRneg. Outcome events included 322 blips and 139 VFs, with incidence rates being significantly lower in patients with BLPCRneg than in those with BLPCRpos [13.0% vs. 23.4% (P < 0.0001) and 5.1% vs. 11.2% (P < 0.0001), respectively]. In multivariable analysis, BLPCRneg was associated with a reduced risk of blips [hazard ratio (HR) 0.58; 95% confidence interval (CI) 0.47–0.73; P < 0.0001] and VF (HR 0.44; 95% CI 0.31–0.62; P < 0.0001).Conclusions: Patients with PCRneg had better virological outcomes than those with PVL < 40 copies/mL but detectable viraemia. This suggests that the ‘no‐signal’ information provided by currently commercially available HIV RNA quantification assays should be used routinely.
- 8 May 2013
- Published by Wiley in HIV Medicine
- Vol. 14 (8) , 509-515
Open AccessAn undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy
Objectives: The aim of the study was to assess whether patients with undetectable viraemia [a negative polymerase chain reaction result (PCRneg)] and those with plasma viral load (PVL) < 40 HIV‐1 RNA copies/mL but a detectable (positive) PCR signal (PCRpos) had different outcomes in terms of the development of blips and virological failure (VF).Methods: A multicentre observational database analysis was carried out. Data for patients whose highly active antiretroviral therapy (HAART) regime had been unchanged for ≥ 6 months by 1 January 2008, whose first two PVL measurements of 2008 were < 40 copies/mL and who had at least five PVL measurements between 1 January 2008 and 31 December 2010 were extracted from a multicentre observational database of 4928 patients receiving HAART. PVL assays used during this period had a detection threshold of 20 or 40 copies/mL. Undetectable PVL at baseline (BLPCRneg) was defined as PCRneg at the first two PVL determinations of 2008. Multivariable Cox regression analysis was performed to investigate factors associated with the occurrence of blips and VF, defined as two consecutive PVL measurements > 40 copies/mL.Results: Of the 1957 patients included in the study (mean age 47 years; median antiretroviral exposure 10.3 years), 1312 had BLPCRneg. Outcome events included 322 blips and 139 VFs, with incidence rates being significantly lower in patients with BLPCRneg than in those with BLPCRpos [13.0% vs. 23.4% (P < 0.0001) and 5.1% vs. 11.2% (P < 0.0001), respectively]. In multivariable analysis, BLPCRneg was associated with a reduced risk of blips [hazard ratio (HR) 0.58; 95% confidence interval (CI) 0.47–0.73; P < 0.0001] and VF (HR 0.44; 95% CI 0.31–0.62; P < 0.0001).Conclusions: Patients with PCRneg had better virological outcomes than those with PVL < 40 copies/mL but detectable viraemia. This suggests that the ‘no‐signal’ information provided by currently commercially available HIV RNA quantification assays should be used routinely.
- Top Cited Papers
- 11 April 2013
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 368 (15) , 1425-1433
Infective Endocarditis
Diagnosis of endocarditis is usually based on clinical, microbiologic, and echocardiographic findings. Treatment involves antimicrobial therapy targeted to the identified organism. Surgical indications include heart failure, uncontrolled infection, and prevention of embolic events.
- 11 April 2013
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 368 (15) , 1425-1433
Top Cited PapersInfective Endocarditis
Diagnosis of endocarditis is usually based on clinical, microbiologic, and echocardiographic findings. Treatment involves antimicrobial therapy targeted to the identified organism. Surgical indications include heart failure, uncontrolled infection, and prevention of embolic events.
- Open Access
- 5 February 2013
- Published by Hindawi Limited in Case Reports in Infectious Diseases
- Vol. 2013, 1-3
Neisseria siccaEndocarditis Complicated by Intracranial and Popliteal Aneurysms in a Patient with a Bicuspid Aortic Valve
We report a case of infective endocarditis due toNeisseria siccacomplicated by intracranial and popliteal aneurysms and hepatic and splenic infarcts in a patient with a bicuspid aortic valve. No predisposing factor other than poor dental condition was found. The patient fully recovered after antibiotic therapy, aortic and mitral valve replacement, endovascular occlusion of the middle-cerebral artery aneurysm, and surgical treatment of the popliteal artery aneurysm.
- 5 February 2013
- Published by Hindawi Limited in Case Reports in Infectious Diseases
- Vol. 2013, 1-3
Open AccessNeisseria siccaEndocarditis Complicated by Intracranial and Popliteal Aneurysms in a Patient with a Bicuspid Aortic Valve
We report a case of infective endocarditis due toNeisseria siccacomplicated by intracranial and popliteal aneurysms and hepatic and splenic infarcts in a patient with a bicuspid aortic valve. No predisposing factor other than poor dental condition was found. The patient fully recovered after antibiotic therapy, aortic and mitral valve replacement, endovascular occlusion of the middle-cerebral artery aneurysm, and surgical treatment of the popliteal artery aneurysm.
- Top Cited PapersOpen Access
- 1 May 2012
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (9) , 1230-1239
Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey
Background. Observational studies showed that the profile of infective endocarditis (IE) significantly changed over the past decades. However, most studies involved referral centers. We conducted a population-based study to control for this referral bias. The objective was to update the description of characteristics of IE in France and to compare the profile of community-acquired versus healthcare-associated IE. Methods. A prospective population-based observational study conducted in all medical facilities from 7 French regions (32% of French individuals aged ≥18 years) identified 497 adults with Duke-Li–definite IE who were first admitted to the hospital in 2008. Main measures included age-standardized and sex-standardized incidence of IE and multivariate Cox regression analysis for risk factors of in-hospital death. Results. The age-standardized and sex-standardized annual incidence of IE was 33.8 (95% confidence interval [CI], 30.8–36.9) cases per million inhabitants. The incidence was highest in men aged 75–79 years. A majority of patients had no previously known heart disease. Staphylococci were the most common causal agents, accounting for 36.2% of cases (Staphylococcus aureus, 26.6%; coagulase-negative staphylococci, 9.7%). Healthcare-associated IE represented 26.7% of all cases and exhibited a clinical pattern significantly different from that of community-acquired IE. S. aureus as the causal agent of IE was the most important factor associated with in-hospital death in community-acquired IE (hazard ratio [HR], 2.82 [95% CI, 1.72–4.61]) and the single factor in healthcare-associated IE (HR, 2.54 [95% CI, 1.33–4.85]). Conclusions. S. aureus became both the leading cause and the most important prognostic factor of IE, and healthcare-associated IE appeared as a major subgroup of the disease.
- 1 May 2012
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (9) , 1230-1239
Top Cited PapersOpen AccessPreeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey
Background. Observational studies showed that the profile of infective endocarditis (IE) significantly changed over the past decades. However, most studies involved referral centers. We conducted a population-based study to control for this referral bias. The objective was to update the description of characteristics of IE in France and to compare the profile of community-acquired versus healthcare-associated IE. Methods. A prospective population-based observational study conducted in all medical facilities from 7 French regions (32% of French individuals aged ≥18 years) identified 497 adults with Duke-Li–definite IE who were first admitted to the hospital in 2008. Main measures included age-standardized and sex-standardized incidence of IE and multivariate Cox regression analysis for risk factors of in-hospital death. Results. The age-standardized and sex-standardized annual incidence of IE was 33.8 (95% confidence interval [CI], 30.8–36.9) cases per million inhabitants. The incidence was highest in men aged 75–79 years. A majority of patients had no previously known heart disease. Staphylococci were the most common causal agents, accounting for 36.2% of cases (Staphylococcus aureus, 26.6%; coagulase-negative staphylococci, 9.7%). Healthcare-associated IE represented 26.7% of all cases and exhibited a clinical pattern significantly different from that of community-acquired IE. S. aureus as the causal agent of IE was the most important factor associated with in-hospital death in community-acquired IE (hazard ratio [HR], 2.82 [95% CI, 1.72–4.61]) and the single factor in healthcare-associated IE (HR, 2.54 [95% CI, 1.33–4.85]). Conclusions. S. aureus became both the leading cause and the most important prognostic factor of IE, and healthcare-associated IE appeared as a major subgroup of the disease.
- 1 April 2012
- Vol. 62 (4) , 511-4
[Epidemiology of infective endocarditis].
In industrialized countries, after the eradication of rheumatic fever, rheumatic valve diseases progressively disappeared and the proportion of post-rheumatic infective endocarditis significantly decreased. Intravenous drug use, prosthetic valves, age-related degenerative valve sclerosis, and invasive procedures have become the most important risk factors for infective endocarditis. These changes resulted in a decreased incidence of streptococcal endocarditis and an increased incidence of staphylococcal endocarditis.
- 1 April 2012
- Vol. 62 (4) , 511-4
[Epidemiology of infective endocarditis].
In industrialized countries, after the eradication of rheumatic fever, rheumatic valve diseases progressively disappeared and the proportion of post-rheumatic infective endocarditis significantly decreased. Intravenous drug use, prosthetic valves, age-related degenerative valve sclerosis, and invasive procedures have become the most important risk factors for infective endocarditis. These changes resulted in a decreased incidence of streptococcal endocarditis and an increased incidence of staphylococcal endocarditis.
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 60
190 Surgery of infective endocarditis analyzed within a one-year population-based study
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 60
190 Surgery of infective endocarditis analyzed within a one-year population-based study
- 30 June 2010
- Published by Elsevier in La Presse Médicale
- Vol. 39 (6) , 701-703
Évolution du profil des endocardites infectieuses : quoi de neuf ?
- 30 June 2010
- Published by Elsevier in La Presse Médicale
- Vol. 39 (6) , 701-703
Évolution du profil des endocardites infectieuses : quoi de neuf ?
- 1 July 2009
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 39 (7-8) , 468-472
Diagnostic différentiel entre méningite bactérienne et méningite virale : apport des examens non microbiologiques
- 1 July 2009
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 39 (7-8) , 468-472
Diagnostic différentiel entre méningite bactérienne et méningite virale : apport des examens non microbiologiques
- 1 November 2008
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 32, S15-S17
Non-staphylococcal Gram-positive bacteraemia without a known source
- 1 November 2008
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 32, S15-S17
Non-staphylococcal Gram-positive bacteraemia without a known source